|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 223/14 | (2006.01) |
| A61K 31/55 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 13/02 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 25/06 | (2006.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/20 | (2006.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/30 | (2006.01) | ||
| A61P 25/32 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07D 223/16 | (2006.01) | ||
| C07D 223/32 | (2006.01) | ||
| C07D 403/04 | (2006.01) | ||
| C07D 409/04 | (2006.01) | ||
| C07D 487/00 | (2006.01) | ||
| C07D 491/00 | (2006.01) | ||
| C07D 491/04 | (2006.01) | ||
| C07D 491/048 | (2006.01) | ||
| C07D 513/00 | (2006.01) |
| (11) | Number of the document | 1411881 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03718323.3 |
| Date of filing the European patent application | 2003-04-11 | |
| (97) | Date of publication of the European application | 2004-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2005-05-04 |
| (46) | Date of publication of the claims translation | 2005-08-25 |
| (86) | Number | PCT/US2003/011076 |
| Date | 2003-04-11 |
| (87) | Number | WO 2003/086306 |
| Date | 2003-10-23 |
| (30) | Number | Date | Country code |
| 372058 P | 2002-04-12 | US | |
| 405495 P | 2002-08-23 | US | |
| 434607 P | 2002-12-18 | US | |
| 410991 | 2003-04-10 | US |
| (72) |
SMITH, Brian, US
SMITH, Jeffrey, US
|
| (73) |
Arena Pharmaceuticals, Inc.,
6166 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 5HT2C receptoriaus moduliatoriai |
| 5HT2C RECEPTOR MODULATORS |
| Payment date | Validity (years) | Amount | |
| 2022-03-21 | 347.00 EUR |